| Trial Status | All trial activities ended |
| Dates | Date of activation: 26-Jan-04 Closed on : 23-Mar-07 |
| Data management at EORTC | Full |
| Phase | 2 |
| Randomized trial | Yes |
| Type | Hemato-malign |
| Targeted Sample size | 84 |
| Number of steps | 1 |
| Drug | Cyclophosphamide Doxorubicin Gemcitabine Prednisone Rituximab Vincristine |
| Study Staff | Igor Aurer (Study Coordinator) - University Hospital Rebro, Zagreb Hilde Breyssens (Project Manager) - EORTC Headquarters, Brussels, hilde.breyssens( at )eortc.be, +32 27741004 |
| Type of cancer | Non Hodgkins Lymphoma |
| Participating Groups | EORTC Lymphoma Group(Coordinating Group) |
| Protocol summary | Cancer.gov (PDQ) ClinicalTrials.gov |
| NCT number | NCT00079261 |
| EudraCT | |
| Protocol documents in PDF (requires password) | Study documentation |